Cost utility analysis of atezolizumab in the treatment of metastatic non-small cell lung cancer

ZHANG Ying, ZENG Xiao-hui, WAN Xiao-min, YI Li-dan, PENG Ye, WANG Li-ting, QIN Shu-xia, SHEN Ya-nan, TAN Chong-qing

Chinese Journal of Hospital Pharmacy ›› 2021, Vol. 41 ›› Issue (8) : 828-832.

PDF(1832 KB)
PDF(1832 KB)
Chinese Journal of Hospital Pharmacy ›› 2021, Vol. 41 ›› Issue (8) : 828-832. DOI: 10.13286/j.1001-5213.2021.08.12
CONTENTS IN BRIEF

Cost utility analysis of atezolizumab in the treatment of metastatic non-small cell lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 41(8): 828-832 https://doi.org/10.13286/j.1001-5213.2021.08.12

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1832 KB)

Accesses

Citation

Detail

Sections
Recommended

/